Member Info for SEA7

yep - all the work done to date is only beginning to show in the numbers. The underlying business is getting stronger and the strategy is delivering as planned. There is a credible work plan in place and based on previous results achieved, there is every expectation that the current plans will yield the desired results. From a share price perspective, the stock is increasing steadily, reflecting the underlying business. It has much further to run.

The website is directors talk.

hTTp://www.***************************/goldplat-plc-ceo-gerard-kisbey-green-second-quarter-profitability/412699989

as long as all goes to plan, it will move to 24p on the 19th april, then go from there on that day onwards buying at 3.1 today would mean at 24p you would be down a touch to begin with.

The birken sellers are getting... initial eur 1 million settled on signature of birken spa another eur 150k on completion milestone payments upto eur50 million, of which eur10 million is payable on admission royalties of 6-9% of episalvan sales for 10 years from first commercial sale. and shares in amryt totalling 30% of the fully diluted issued share capital ........... After paying out eur11.1million - the old cash balance from fastnet equity is about gone. Then.. pay $100k in cash for somtherapeutics less liabilities if over $150k pay $4.15m in shares for sompharmaceuticals. This will leave the EUR10 million from the placing to fund the eb trials. It won't be long before the additional funding is sought, if not already being looked at.

from the rns today.. The Enlarged Group will utilise the net proceeds of the placing to focus on the opportunity presented within the EB market as described below. Subject to securing additional capital, which may come from alternative sources such as licencing deals or venture debt, the Enlarged Group would have the ability to exploit its other assets, Episalvan in respect of PTWs which has been approved for use in Europe and its preclinical assets focused on Acromegaly and Cushing's disease, Meaning, after the placing and a bit of time, they will be looking for further funding.

Iirc they had about £9m in cash at suspension, they are taking over amryt in a £29.6m reverse takeover and raising £10m in a placing, which when added up comes to about the £50m cap.

Nope, they will consolidate 8 for 1, issue the consideration shares for the purchase of amryt, carry out the placing at 24p, to raise £10m then, in addition to the warrants/options there will be, on the 19th April, 236,687,257 shares in issue, fully diluted. At 24p this is a cap of £56.8m, without options/warrants it is 208,339,632 x 24p which is a mcap of £50m as indicated in the rns's today. The stock will open at 24p and go from there.

There is every chance it will run higher on the 19th april, however, it may slowly decline below that as the days roll on. Wouldn't be the first aim stock I have seen do that.

There will be an 8 for 1 consolidation, with the placing price at 24p. Buying over 3p today means a loss to start with, after the consolidation. I will be waiting for the price to get down to three pence, or I will wait until after the whole process is completed and look to buy in, if and when the price goes below the 24p price, which is possible. Buy £2k today at 3.4p you get 58,823 shares - consolidate 8 for 1, you are left with 7,352 shares. Say the stock starts at 24p placing price on 19th april, your stock would be worth 7,352 x 24p = £1,764.28. Buy £2k at 3p, you get 66,666 shares, consolidate 8 for 1 you get 8,333 shares x 24p = £1999.92. No point buying at over 3p, prior to consolidation.

when I say a small amount of finance, this would be via an investment from someone else, not a loan. He was clear that it was easier to raise £10m or £20m, yet when you only want £1m or £2m it is harder.

in the interview posted here, earlier today, gerard stated that the could not raise equity at these price levels and would be unable to raise such a small amount of finance, so would be funding the CIL plant move to kenya, internally. There will be no placing. Just PI's that are getting out at these levels, for personal reasons.

picked up a few more today

tks - very good interview

clainy, The position will have improved significantly since 1st jan as some of the improvements made only came online towards the end of H1. H2 will see these benefits across the whole period and the full year results are likely to be significantly better. There is further to run with this, especially as they have a well defined and structured capex plan, which is delivering as designed so far. Gerard stated, in the recent interview "with a fair wind behind gold, it will be a good year for us"

from the interims, a few days ago... The CIL circuit is currently being dismantled and containerised for shipment to Kilimapesa in Kenya. This will free up space on the constrained site in Tema, Ghana for the potential expansion of other revenue streams. Plans for the final rehabilitation of the tailings deposition dam (which had reached capacity and was the reason for the cessation of the CIL process) have been completed with work planned to commence during the period to June 2016. The rehabilitation of the dam will also free up significant space on site. During the period a shotblast facility was constructed and commissioned at GRG for the processing of steel mill liners and production of a concentrate for export. This represents a new revenue stream for GRG. Contracts for sourcing of material have been signed post December 2015 and deliveries of liners have commenced. Plans are being prepared to install an elution column at the Tema site to improve the processing of carbon and to produce bullion for export in terms of our licence agreement with the Minerals Commission. Strategically, Goldplat continues to view GRG as a significant growth opportunity with plans to source material for GRG from both West Africa and South America ongoing

Read Kimboy's posts as well on advfn.. he is very well informed on goldplat.

thanks for the kind feedback!!!

The trade was timed at 16.24 and reported at 17.24. I saw the bid suddenly move up to 5.5p followed by a small sale of 24k shares at 5.5p. Looks like that trade was the cause of it.

One late trade reported after hours, a buy at 5.75p for 257,250 shares.